The better efficacy of conjugate 2 on orthotopically developed CD13(−) HT-29 colon cancer might be explained by the faster rearrangement of conjugate 2 to isoDGR derivative that recognizes integrins in comparison with conjugate 1. The gene discussed is ANPEP; the disease is colonic neoplasm.